Comparison of the [F]-FDG and [F]-FLT PET Tracers in the Evaluation of the Preclinical Proton Therapy Response in Hepatocellular Carcinoma.
Fiche publication
Date publication
avril 2021
Journal
Molecular imaging and biology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BRASSE David, Pr LAQUERRIERE Patrice, Dr BURCKEL Hélène, Dr FINCK Christian
Tous les auteurs :
Brasse D, Burckel H, Marchand P, Rousseau M, Ouadi A, Vanstalle M, Finck C, Laquerriere P, Boisson F
Lien Pubmed
Résumé
The main objective of the present study was to compare the 2-deoxy-2-[F]fluoro-D-glucose ([F]-FDG) and 3'-[F]fluoro-3'-deoxythymidine ([F]-FLT) PET imaging biomarkers for the longitudinal follow-up of small animal proton therapy studies in the context of hepatocellular carcinoma (HCC).
Mots clés
Hepatocellular carcinoma, Longitudinal study, PET, Preclinical studies, Proton therapy
Référence
Mol Imaging Biol. 2021 Apr 13;: